Compounds > indican
Page last updated: 2024-08-21

indican and Anemia, Sickle Cell

indican has been researched along with Anemia, Sickle Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dutta, D; Li, K; Lim, SH; Methe, B1
Dutta, D; Lim, SH; Methe, B; Morris, A1

Trials

1 trial(s) available for indican and Anemia, Sickle Cell

ArticleYear
Rifaximin on intestinally-related pathologic changes in sickle cell disease.
    American journal of hematology, 2020, Volume: 95, Issue:4

    Topics: Abdominal Pain; Anemia, Sickle Cell; Anti-Bacterial Agents; Bacterial Translocation; Biomarkers; Dysbiosis; Gastrointestinal Agents; Gastrointestinal Microbiome; Humans; Indican; L-Selectin; Neutrophil Activation; Rifaximin

2020

Other Studies

1 other study(ies) available for indican and Anemia, Sickle Cell

ArticleYear
Elevated urinary 3-indoxyl sulfate in sickle cell disease.
    American journal of hematology, 2019, Volume: 94, Issue:6

    Topics: Anemia, Iron-Deficiency; Anemia, Sickle Cell; Animals; Female; Humans; Indican; Male

2019